2022/1/24 Lijuan’s paper is accepted by J. Am. Chem. Soc., Congrats to Lijuan!

2022/1/24 Lijuan’s paper titled with “Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy” is accepted by J. Am. Chem. Soc., Congrats to Lijuan! Read the paper at https://pubs.acs.org/doi/10.1021/jacs.1c09574.